McCartney leaving Genesis Bioventures

Diagnostic company GBIW said Greg McCartney will depart as president, CEO and chairman. Douglas Lane, president of Experigen Management, will serve as interim president and CEO and also will serve as chairman until the next annual shareholder meeting. McCartney will remain a director and will serve as a consultant to the company. ...